0000950170-23-070835.txt : 20231215
0000950170-23-070835.hdr.sgml : 20231215
20231215173117
ACCESSION NUMBER: 0000950170-23-070835
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231213
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Provost Miriam
CENTRAL INDEX KEY: 0001773663
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38891
FILM NUMBER: 231491513
MAIL ADDRESS:
STREET 1: 2000 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TransMedics Group, Inc.
CENTRAL INDEX KEY: 0001756262
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
BUSINESS PHONE: 9785520900
MAIL ADDRESS:
STREET 1: 200 MINUTEMAN ROAD
CITY: ANDOVER
STATE: MA
ZIP: 01810
4
1
ownership.xml
4
X0508
4
2023-12-13
0001756262
TransMedics Group, Inc.
TMDX
0001773663
Provost Miriam
C/O TRANSMEDICS GROUP, INC.
200 MINUTEMAN ROAD
ANDOVER
MA
01810
false
true
false
false
VP, Global Regulatory Affairs
false
Common Stock
2023-12-13
4
M
false
415
16.14
A
24026
D
Common Stock
2023-12-13
4
S
false
206
75.10
D
23820
D
Common Stock
2023-12-13
4
M
false
1632
66.10
A
25452
D
Common Stock
2023-12-13
4
S
false
1509
75.10
D
23943
D
Common Stock
2023-12-13
4
M
false
3597
38.46
A
27540
D
Common Stock
2023-12-13
4
S
false
2407
75.10
D
25133
D
Common Stock
2023-12-15
4
G
false
1785
0.00
D
23348
D
Stock Option (Right to Buy)
16.14
2023-12-13
4
M
false
415
0.00
D
2030-02-27
Common Stock
415
7811
D
Stock Option (Right to Buy)
66.10
2023-12-13
4
M
false
1632
0.00
D
2033-02-20
Common Stock
1632
7073
D
Stock Option (Right to Buy)
38.46
2023-12-13
4
M
false
3597
0.00
D
2031-02-24
Common Stock
3597
7813
D
The exercise followed the sell-to-cover process, whereby a portion of the shares acquired through the exercise were sold in the open market, with the proceeds used to fund the aggregate exercise price of the options.
On December 15, 2023, the reporting person donated 1,785 shares of directly owned common stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 20, 2023.
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 24, 2021.
By: /s/ Stephen Gordon, Attorney-in-Fact
2023-12-15